Public Board of Directors papers 260123

Key points noted: • 42% increase in the number compared to the previous financial year; consistent with other Trusts. • 1 complaint was referred to the Parliamentary and Health Service Ombudsman (PHSO) in year providing assurance that the Trust is dealing well with complaints. • Team now have the extra resource to support dealing with complaints. • 11 claims were opened in-year, 10 clinical negligence and 1 employer’s liability. 12 claims were closed 12 in the period with 7 claims settled and 5 claims successfully defended. • 2 high value claims settled in-year, which had been on-going for several years. Each claim was valued in excess of £1million. • GIRFT data reviewed and gained assurance of no concern with Trust procedures. Comments to be fed back to the national team. No actions from Committee review. Key points noted: • 62-day compliance relates to 23.3% of overall referrals to the Trust. • 24-day compliance seen a steady improvement from Aug - Oct. • Consistently achieved all 31-day standards. • 104 days is monitored weekly as this can lead to more complex patients. • There has been an improvement with the radiotherapy booking forms, this was not a capacity issue, identified as a process issue. No actions from Committee review.

Learning from Complaints & Claims

1.2

High

Cancer waiting times

6.1

High

The Committee Chair will note any actions required by Board and make escalations to Board as necessary. 3 Recommendation The Board are asked to note the reports received for assurance by the Quality Assurance Committee in November 2022.

13